ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $10,000 | -44.4% | 10,000 | -44.4% | 0.00% | – |
Q2 2021 | $18,000 | +125.0% | 18,000 | +125.0% | 0.00% | – |
Q1 2021 | $8,000 | 0.0% | 8,000 | +14.3% | 0.00% | – |
Q4 2020 | $8,000 | 0.0% | 7,000 | -12.5% | 0.00% | – |
Q3 2020 | $8,000 | -11.1% | 8,000 | 0.0% | 0.00% | – |
Q2 2020 | $9,000 | +28.6% | 8,000 | +14.3% | 0.00% | – |
Q1 2020 | $7,000 | -92.1% | 7,000 | -91.0% | 0.00% | – |
Q4 2019 | $89,000 | -20.5% | 78,000 | -20.4% | 0.00% | – |
Q3 2019 | $112,000 | -84.9% | 98,000 | -82.2% | 0.00% | -100.0% |
Q1 2019 | $744,000 | +40.9% | 550,000 | +10.0% | 0.00% | – |
Q4 2017 | $528,000 | -84.7% | 500,000 | -84.7% | 0.00% | -100.0% |
Q3 2017 | $3,452,000 | +146.6% | 3,268,000 | +147.6% | 0.00% | +200.0% |
Q2 2017 | $1,400,000 | -41.5% | 1,320,000 | -46.9% | 0.00% | -50.0% |
Q1 2017 | $2,392,000 | +963.1% | 2,484,000 | +1013.9% | 0.00% | – |
Q4 2016 | $225,000 | +1025.0% | 223,000 | +1138.9% | 0.00% | – |
Q4 2015 | $20,000 | – | 18,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 16,935,000 | $17,946,697,000 | 3.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $48,504,000 | 2.18% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $21,312,000 | 1.66% |
LINDEN ADVISORS LP | 34,494,000 | $36,562,000 | 1.30% |
WOLVERINE ASSET MANAGEMENT LLC | 96,239,000 | $101,731,000 | 1.13% |
MACKAY SHIELDS LLC | 24,155,000 | $25,567,000 | 0.95% |
Verition Fund Management LLC | 10,200,000 | $10,799,000 | 0.87% |
Jabre Capital Partners S.A. | 4,000,000 | $4,243,000 | 0.82% |
ADVENT CAPITAL MANAGEMENT /DE/ | 38,030,000 | $40,330,000 | 0.76% |
AQR Arbitrage LLC | 44,600,000 | $47,220,000 | 0.51% |